Zaleplon 10 mg Capsules Under Non-Fasting Conditions
Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the relative bioavailability of zaleplon 10 mg
capsules(manufactured and distributed by TEVA Pharmaceuticals USA) with that of SONATA® 10mg
capsules (Wyeth-Ayerst Pharmaceuticals) in healthy, non-smoking, adult subjects under
non-fasting conditions.